| No. | Recommendations | GR | LoE | Sources |
|---|---|---|---|---|
| 8.1. | Patients with stage IA grade 1 ovarian cancer after complete operative staging must not receive adjuvant chemotherapy. | A | 1+ | Primary studies: 96, 97, 98, 99, 100, 101, 102, 103, 104 |
| 8.2. | Patients with stage IC or IA/B, grade 3 ovarian cancer must receive platinum-based chemotherapy (6 cycles). | A | 1+ | Primary studies: 96, 97, 98, 99, 100, 101, 102, 103, 104 |
| 8.3. | Patients with stage IAG2, IB G1/2 ovarian cancer can be offered platinum-based chemotherapy. | 0 | 1+ | Primary studies: 96, 97, 98, 99, 100, 101, 102, 103, 104 |
| 8.4. | The therapy should include carboplatin and consist of 6 cycles. | B | 1+ | Guidelines: 1, 2 Primary studies: 67, 99, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.